<?xml version="1.0"?>
<law>
  <structure>
    <unit label="title" identifier="ghg" order_by="" level="1"/>
    <unit label="chapter" identifier="18-1001" order_by="" level="2"/>
  </structure>
  <section_number>ghg-18-1001</section_number>
  <catch_line/>
  <text>As funds are available, the Department shall:<section prefix=""><section prefix="(1)">Conduct a needs assessment to determine the incidence of the hepatitis B virus and hepatitis C virus in the State;</section><section prefix="(2)">Initiate a statewide public awareness campaign targeting vulnerable populations and health care providers in the State to urge hepatitis B virus and hepatitis C virus education and testing;</section><section prefix="(3)">Coordinate with other units of State government, including the Department of Public Safety and Correctional Services and the Veterans' Administration, to activate a hepatitis C virus plan for the education, testing, and treatment of the populations within the jurisdiction of the units;</section><section prefix="(4)">Solicit funding from the private sector and units of federal, state, and local government for hepatitis B virus and hepatitis C virus outreach;</section><section prefix="(5)">Provide funding for hepatitis C virus pilot programs, which may include programs in methadone clinics or programs for the Department of Correctional Services population;</section><section prefix="(6)">Review and recommend initiatives to promote advocacy, education, physician outreach, and awareness of the hepatitis B virus and hepatitis C virus;</section><section prefix="(7)">Assess the feasibility of creating a Hepatitis C Virus Administration in the Department and examine methods to maximize existing resources to raise awareness of the hepatitis virus;</section><section prefix="(8)">Implement the 2005 Report of the Hepatitis C Advisory Council;</section><section prefix="(9)">Coordinate with the Maryland Office of Minority Health and Health Disparities to develop a hepatitis B virus plan and a hepatitis C virus plan for the education, testing, and treatment of high risk populations and ethnic and racial populations who are affected disproportionately by the hepatitis B and hepatitis C viruses, including the Asian population and African immigrants;</section><section prefix="(10)">Develop a plan to increase the availability of hepatitis B virus vaccinations in the State, in accordance with recommendations from the Centers for Disease Control and Prevention;</section><section prefix="(11)">Develop recommendations to improve the awareness and the affordability of medications for treating the hepatitis C virus; and</section><section prefix="(12)">Collaborate with the Maryland Insurance Administration to make recommendations regarding insurance coverage for the treatment of the hepatitis C virus.</section></section></text>
</law>
